We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,969 results
  1. lncRNA CDKN2B-AS1 regulates collagen expression

    The long noncoding RNA CDKN2B-AS1 harbors a major coronary artery disease risk haplotype, which is also associated with progressive forms of the oral...

    Weiwei Shi, Jiahui Song, ... Arne S. Schaefer in Human Genetics
    Article Open access 04 June 2024
  2. EPB41L4A-AS1 is required to maintain basal autophagy to modulates Aβ clearance

    Alzheimer’s disease (AD) is the most common neurodegenerative disorder characterized by the deposition of β-amyloid (Aβ) plaques. Aβ is generated...

    Ziqiang Wang, Ruomei Wang, ... Kun Li in npj Aging
    Article Open access 04 May 2024
  3. Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors

    Recent studies have increasingly highlighted the aberrant expression of SLC16A1-AS1 in a variety of tumor types, where it functions as either an...

    Bing Liao, Jialing Wang, ... ** Ouyang in Cancer Cell International
    Article Open access 30 March 2024
  4. LOXL1-AS1 inhibits JAK2 ubiquitination and promotes cholangiocarcinoma progression through JAK2/STAT3 signaling

    This study thoroughly investigated the role of the long non-coding RNA LOXL1-AS1 in the pathogenesis of cholangiocarcinoma (CCA). Through...

    Shaobo Yu, **n Gao, ... **ngming Jiang in Cancer Gene Therapy
    Article 24 January 2024
  5. LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis

    Background

    Breast cancer (BC) is a prevalent malignancy with complex etiology and varied clinical behavior. Long non-coding RNAs (lncRNAs) have...

    Yuqin Ding, Yuting Huang, ... Yiding Chen in Journal of Translational Medicine
    Article Open access 26 November 2023
  6. LncRNA BBOX1-AS1 Contributes to Laryngeal Carcinoma Progression by Recruiting SRSF1 to Maintain EFNB2 mRNA Stability

    Laryngeal cancer is a common malignancy of the larynx with a generally poor prognosis. This study systematically assessed the functional role of...

    **aowen Zhu, Xuan Li, ... Jian Ni in Biochemical Genetics
    Article 04 July 2024
  7. SOX21-AS1 Augmented Cervical Cancer Growth by Triggering FZD3 to Activate the Wnt/β-Catenin Signaling Pathway

    Long non-coding RNA (LncRNA) SOX21-AS1 has been reported that it plays an important role in biological processes of several cancers. However, how it...

    Yanfang Zhi, Peipei Du, ... **aofu Li in Biochemical Genetics
    Article 21 March 2024
  8. LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism

    Osteosarcoma (OS) is a highly malignant tumor, and its dysregulated lipid metabolism is associated with tumorigenesis and unfavorable prognosis....

    Feng Cai, Luhua Liu, ... Yangyan Yi in BMC Cancer
    Article Open access 02 February 2024
  9. LncRNA SLCO4A1-AS1 suppresses lung cancer progression by sequestering the TOX4-NTSR1 signaling axis

    Background

    Metastasis is a multistep process involving the migration and invasion of cancer cells and is a hallmark of cancer malignancy. Long...

    Yi-Ling Chen, Yi-Nan Liu, ... **-Yuan Shih in Journal of Biomedical Science
    Article Open access 19 September 2023
  10. ROR1-AS1 might promote in vivo and in vitro proliferation and invasion of cholangiocarcinoma cells

    Long non-coding RNAs (lncRNAs) play important roles in many pathophysiological processes, including cancer progression. Namely, lncRNA...

    Xueliang Li, Zhaowei Sun, ... Yujie Feng in BMC Cancer
    Article Open access 28 September 2023
  11. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1

    Background

    Acute myeloid leukemia (AML) is a hematopoietic malignancy. Chidamide has shown anti-cancer effect in different malignancies. The function...

    Changmei Hu, **ao Fu, ... Jie Peng in DARU Journal of Pharmaceutical Sciences
    Article 06 November 2023
  12. lncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1

    Background

    The vast majority of lncRNAs have low expression abundance, which greatly limits their functional range and impact. As a high expression...

    Shanshan Qin, Yue Liu, ... Dandan Li in Journal of Experimental & Clinical Cancer Research
    Article Open access 05 July 2024
  13. LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma

    Background

    Long non-coding RNAs (lncRNAs) are key regulators of the 6-methyladenosine (m6A) epigenetic modification, playing a role in the initiation...

    Meiting Rong, Ming Zhang, ... Hui-yi Lu in Cancer Cell International
    Article Open access 25 March 2024
  14. Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer

    Background

    Long noncoding RNA thymopoietin-antisense RNA 1 (TMPO-AS1) is recognized as a participant in cancer progression. Nevertheless, its...

    Yingmin **, Aimin Jiang, ... Yue Lu in BMC Cancer
    Article Open access 21 February 2024
  15. Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis

    Background

    Metastasis is the primary cause of recurrence and death in patients with papillary thyroid carcinoma (PTC). LncRNA ACTA2-AS1, a long...

    Shuhui Wu, **g**g Zhu, ... **ang Chen in Clinical Epigenetics
    Article Open access 09 January 2024
  16. FOXP4-AS1 promotes CD8+ T cell exhaustion and esophageal cancer immune escape through USP10-stabilized PD-L1

    Abstract

    Esophageal cancer (EC) is the 9th most frequently diagnosed malignancy globally with unfavorable prognosis. Immune escape is one of the...

    Guo-yi Shen, Yi Zhang, ... Shao-bin Yang in Immunologic Research
    Article 30 April 2024
  17. Long noncoding RNA TMPO-AS1 upregulates BCAT1 expression to promote cell proliferation in nasopharyngeal carcinoma via microRNA let-7c-5p

    Background

    Long non-coding RNA (lncRNA) is a group of RNA transcripts that contribute to tumor development by post-transcriptionally regulating...

    Huan Wang, Fuming Zhou, ... ** Wang in Genes and Environment
    Article Open access 27 June 2024
  18. LncRNA PGM5-AS1 inhibits non-small cell lung cancer progression by targeting miRNA-423-5p/SLIT2 axis

    Non-small cell lung cancer (NSCLC) is a common and aggressive primary malignancy worldwide. Dysregulation of long non-coding RNAs (lncRNAs) has been...

    Jiajun Wang, Jun Ye, ... Shun Xu in Cancer Cell International
    Article Open access 20 June 2024
  19. DHRS4-AS1 regulate gastric cancer apoptosis and cell proliferation by destabilizing DHX9 and inhibited the association between DHX9 and ILF3

    Gastric cancer (GC) causes millions of cancer-related deaths due to anti-apoptosis and rapid proliferation. However, the molecular mechanisms...

    Lei **ao, Yang zhang, ... Chen Lai in Cancer Cell International
    Article Open access 01 December 2023
  20. GATA6-AS1 suppresses epithelial–mesenchymal transition of pancreatic cancer under hypoxia through regulating SNAI1 mRNA stability

    Pancreatic ductal adenocarcinoma (PDAC) is characterized by a hypoxic microenvironment, a high rate of heterogeneity as well as a high likelihood of...

    Yunhui Zhou, **nyi Zhou, ... Lin Zhou in Journal of Translational Medicine
    Article Open access 06 December 2023
Did you find what you were looking for? Share feedback.